MedTech & Digital Health
Regulatory and Quality strategy for medical devices, SaMD, digital health platforms and connected products that need a defensible route to market.
Where We Help
510(k), De Novo and market pathway strategy; private-label and manufacturer-role questions; intended use and claims; technical documentation; design and software lifecycle evidence; clinical and performance evidence; ISO 13485 readiness; UDI/GUDID; supplier quality; and Quality System maturity.
The Decision We Protect
Whether the product, evidence package and Quality System can support the intended commercial path before submission timelines, supplier commitments and launch claims become expensive to reverse.